1. Home
  2. TV vs COAG Comparison

TV vs COAG Comparison

Compare TV & COAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grupo Televisa S.A.

TV

Grupo Televisa S.A.

N/A

Current Price

$2.24

Market Cap

2.2B

Sector

Industrials

ML Signal

N/A

COAG

Hemab Therapeutics Holdings Inc. Common Stock

N/A

Current Price

$39.87

Market Cap

1.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TV
COAG
Founded
1969
2020
Country
Mexico
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.9B
IPO Year
1997
2026

Fundamental Metrics

Financial Performance
Metric
TV
COAG
Price
$2.24
$39.87
Analyst Decision
Buy
Strong Buy
Analyst Count
9
7
Target Price
$3.79
★ $63.00
AVG Volume (30 Days)
★ 1.2M
468.0K
Earning Date
10-29-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.01
$27.38
52 Week High
$3.49
$55.42

Technical Indicators

Market Signals
Indicator
TV
COAG
Relative Strength Index (RSI) 46.69 51.39
Support Level $2.18 $28.46
Resistance Level $2.91 $51.07
Average True Range (ATR) 0.10 3.87
MACD 0.01 -0.43
Stochastic Oscillator 59.21 30.95

Price Performance

Historical Comparison
TV
COAG

About TV Grupo Televisa S.A.

Televisa is one of the leading telecom firms in Mexico. Its cable arm, Izzi, holds networks that pass 20 million Mexican homes and provide broadband service to nearly 6 million customers. The firm is also one of the largest pay-television providers in Mexico, with nearly 4 million customers. Televisa owns Sky Mexico, the country's only satellite-TV provider, serving about 4 million customers. After merging its traditional media business into Univision, Grupo Televisa owns a 43% stake in the combined entity TelevisaUnivision. Grupo Televisa spun off several smaller businesses, including magazine publishing, three of Mexico's professional soccer teams, and Azteca Stadium in February 2024, under the name Ollamani.

About COAG Hemab Therapeutics Holdings Inc. Common Stock

Hemab Therapeutics Holdings Inc is a clinical-stage biotechnology company developing therapies for the treatment of blood coagulation disorders. It focuses on discovering, developing, and commercializing treatments for conditions such as Glanzmann thrombasthenia, Factor VII deficiency, and von Willebrand disease. Its flagship candidate, sutacimig (HMB-001), is a bispecific antibody currently in clinical trials for the prophylactic treatment of Glanzmann thrombasthenia and Factor VII deficiency. The company has one operating segment, engaged in the research and development of prophylactic therapeutics for bleeding disorders.

Share on Social Networks: